Methylphenidate Transdermal Patch (Daytrana), ADHD, & the FDA: FDA Briefing Information
Neuroscience

Methylphenidate Transdermal Patch (Daytrana), ADHD, & the FDA: FDA Briefing Information


Briefing Information for the FDA's psychopharmacologic drugs advisory committee meeting on Friday.
-
Anthony H. Risser
neuroscience | neuropsychology | brain | ADHD




- Daytrana (methylphenidate Patch) & Adhd
From the website of The Washington Post: FDA OKs First Attention Deficit Patch By ANDREW BRIDGES The Associated Press Thursday, April 6, 2006; 8:06 PM WASHINGTON -- The FDA on Thursday approved the first skin patch to treat attention deficit hyperactivity...

- Methylphenidate
From The New York Times:Panel Recommends Warnings for Ritalin and Other Stimulants By THE ASSOCIATED PRESS Published: February 9, 2006 Filed at 4:13 p.m. ET WASHINGTON (AP) -- Federal science advisers voted narrowly Thursday to recommend the most serious...

- Methylphenidate Transdermal Patch (daytrana), Adhd, & The Fda: Thursday And Friday
THURSDAY: From The Washington Post website:Problem Found With Potential ADHD Patch The Associated Press Thursday, December 1, 2005; 3:01 PM WASHINGTON -- A patch developed to treat attention deficit hyperactivity disorder in children received a negative...

- In The Weeklies: Attention Deficit Hyperactivity Disorder (adhd)
This week's Morbidity and Mortaility Weekly Report (MMWR) includes an article about the prevelance and treatment of ADHD: Mental Health in the United States: Prevalence of Diagnosis and Medication Treatment for Attention-Deficit/Hyperactivity Disorder...

- Adhd Treatment
The full-text contents of the following article is available on the Pediatrics website at this link [Click here]: Ronald T. Brown, Robert W. Amler, Wendy S. Freeman, James M. Perrin, Martin T. Stein, Heidi M. Feldman, Karen Pierce, Mark L. Wolraich and...



Neuroscience








.